SearchCatalogResearchCommunityTools
Research & Educational Use Only. This protocol guide is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before beginning any research protocol.
Neuroprotective Peptide MixEvidence Grade: A (Approved Drug in 40+ Countries)

Cerebrolysin Protocol Guide

Cerebrolysin is a brain-derived peptide preparation containing low-molecular-weight neuropeptides and free amino acids obtained from purified porcine brain tissue. Approved as a pharmaceutical in over 40 countries for stroke recovery, traumatic brain injury, and dementia, it contains neurotrophic factors that mimic BDNF, GDNF, NGF, and CNTF. Cerebrolysin is one of the most clinically studied neuroprotective agents with over 200 clinical trials. This protocol covers administration from a 10mL pre-mixed solution via intramuscular injection at 5mL daily in 10-20 day cycles, and neuroprotective stacking.

Protocol Overview

Compound
Cerebrolysin (Standardized porcine brain protein hydrolysate — peptide complex)
Category
Neurotrophic Complex / Neuroprotective
Mechanism
Contains BDNF, NGF, CNTF, and other neurotrophic factors; promotes neuronal survival, synaptogenesis, and neuroprotection
Structure
Low-molecular-weight neuropeptides and free amino acids from purified porcine brain tissue
Half-Life
~hours (peptide mixture, bioactive components)
Vial Size
10mL pre-mixed ampule (215.2 mg/mL, pharmaceutical grade)
Reconstitution
None required — pre-mixed solution, draw directly from ampule
Route
Intramuscular (IM) injection or slow IV infusion (clinical settings only)
Frequency
Daily × 10–20 days per cycle (Khavinson protocol)
Cycle Length
10–20 days on, 2–3 months off; 2–3 cycles per year

Dosing Protocol

ProtocolDoseFrequencyRouteDuration
Standard5mLOnce dailyIntramuscular (IM)10-20 day cycle
Intensive10mLOnce dailyIntramuscular (IM)10-20 day cycle

Cycling: 10-20 days on, followed by 2-3 months off. Repeat 2-3 cycles per year. For volumes above 5mL, consider splitting between two injection sites.

Administration — No Reconstitution Needed

Cerebrolysin comes as a pre-mixed solution in ampules. No reconstitution required. Draw directly from ampule.

Materials Needed

  • Cerebrolysin 10mL ampule (pre-mixed solution)
  • 3-5mL syringe with 21-23 gauge needle for drawing
  • Injection needle (21-23 gauge, 1-1.5 inch for IM)
  • Alcohol swabs

Step-by-Step Process

  1. Open the ampule by snapping the neck at the score mark
  2. Draw the desired volume (5mL standard, up to 10mL intensive) using a syringe
  3. Switch to a fresh injection needle
  4. Select IM injection site (deltoid, gluteal, or vastus lateralis)
  5. Clean injection site with alcohol swab and administer IM
  6. For volumes >5mL, split between two injection sites
VolumeProtocolRoute
1mLLow / StarterIM
2mLConservativeIM
5mLStandardIM
10mLIntensiveIM

Administration Guide

IM Injection Sites

  • Deltoid: Upper arm, alternate sides
  • Gluteal: Upper outer quadrant
  • Vastus lateralis: Outer mid-thigh
  • For volumes >5mL, split dose between two sites

Timing & Storage

  • Timing: Morning administration recommended
  • Ampule duration: 1 ampule = 1-2 days at 5-10mL/day
  • Storage: Room temperature, protect from light
  • Do not use partially used ampules — discard remainder

Expected Timeline

Day 1-3
Protocol initiation. Some subjects report subtle improvements in mental clarity and focus within the first few days.
Week 1-2
Noticeable cognitive improvements for many subjects. Enhanced working memory, verbal fluency, and processing speed commonly reported.
Week 3-4
Synaptogenesis effects compound. Subjects often report improved learning ability, spatial memory, and creative problem-solving capacity.
Week 5-8
Full protocol effects realized. Sustained cognitive enhancement. Some effects may persist after protocol completion due to structural synaptic changes.

Side Effects & Monitoring

Common Side Effects

  • Injection site pain or irritation (IM)
  • Dizziness or headache during initial days
  • Mild nausea
  • Fever (rare)

Cerebrolysin is an approved pharmaceutical in over 40 countries with extensive clinical trial data (200+ trials). Side effects are generally mild and transient.

Precautions

  • Do not use in patients with epilepsy or severe renal impairment
  • Caution in patients with allergic diathesis
  • IM injection only — do not administer IV push (IV drip only in clinical settings)
  • Not recommended during pregnancy or breastfeeding
  • Monitor for hypersensitivity reactions

Stacking Recommendations

Compatible Compounds

  • NAD+: Cellular energy support for neuronal metabolism
  • Dihexa: HGF potentiator for synaptogenic synergy
  • Semax: Complementary BDNF-pathway nootropic
  • Selank: Anxiolytic support during cognitive enhancement
  • BPC-157: Systemic repair and neuroprotective support

Popular Stacks

  • Neurotrophic Stack: Cerebrolysin 5mL IM/day + Semax 600mcg/day intranasal
  • Neuroprotective: Cerebrolysin 5mL IM/day + NAD+ IV/SubQ + BPC-157
  • Cognitive Recovery: Cerebrolysin + Dihexa (oral) + Selank intranasal

Blood Work Recommendations

PanelMarkersTiming
Basic PanelCBC, CMPBaseline, Week 4
Liver FunctionALT, AST, GGTBaseline, Week 4
KidneyBUN, creatinine, eGFRBaseline, Week 4
InflammatoryCRP, homocysteineBaseline

Monitoring is primarily precautionary given the limited human safety data. Track liver and kidney markers to ensure no organ stress from the compound.

★ OFFICIAL SPONSOR
BioRoot AI
Free Functional Assessment
AI-powered root cause analysis & care plan
Start Free
Paid partnership · Learn more

Related Resources

Semax Protocol PE-22-28 Protocol Pinealon Protocol Dosing Calculator Reconstitution Calculator Bloodwork Planner Stack Checker Peptide Catalog
Share & Save
𝕏 Share on Twitter 📱 Share on Reddit 💬 WhatsApp ✉️ Email 🔗 Copy Link 🖨️ Print / Save PDF Save to Favorites